ArticleJournal of biological engineering2026
Neuroprotective effects of C-phycocyanin and allophycocyanin from Spirulina purified using a newly developed method: in vitro barrier permeability, antioxidant and anti-inflammatory activities.
Article in Journal of biological engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phycobiliproteins, particularly C-phycocyanin (C-PC) and allophycocyanin (APC), are major bioactive pigments in Arthrospira platensis (Spirulina) with well-documented antioxidant properties, yet their individual neuroprotective potential and bioavailability remain poorly characterized. Here, we developed an efficient, potentially scalable, two-step ultrasound-based extraction followed by membrane chromatography to obtain analytical-grade purity C-PC and APC from fresh A. platensis biomass. Both purified phycobiliproteins, together with the crude extract (CE), demonstrated relevant cell viability up to 35 µg/mL in SH-SY5Y neuronal and BV2 microglial cells. In vitro assays revealed that APC exhibited significantly higher ferric-reducing antioxidant power (FRAP) than C-PC, while both phycobiliproteins effectively reduced intracellular ROS levels and protected SH-SY5Y cells from tert-butyl hydroperoxide-induced oxidative stress, with C-PC and APC showing the strongest cytoprotective effects. All preparations also significantly decreased LPS-induced nitric oxide production in BV2 microglia, indicating anti-inflammatory activity. Using Caco-2 monolayers, we demonstrated for the first time that both purified C-PC and APC exhibit time-dependent, low but moderate transcellular permeability, while preserving monolayer integrity. Fluorescence microscopy confirmed substantial intracellular uptake in SH-SY5Y neurons (punctate cytoplasmic pattern) and lower, yet detectable, internalization in BV2 microglia. These findings highlight distinct yet complementary bioactivities of highly purified C-PC and APC and provide the first evidence of their ability to cross physiological barriers in vitro, offering new mechanistic insights into their potential as neuroprotective nutraceuticals targeting oxidative and neuroinflammatory processes in the central nervous system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.